N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors
Graphical abstract
A series of N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides (II) targeting c-Met and VEGFR2 tyrosine kinases, based on our previous acetylthiourea series (I), was designed and synthesized. The new compounds were potent against these two enzymes with IC50 values in the low nanomolar range in vitro, possessed favorable pharmacokinetic profiles and showed high efficacy in vivo in several human tumor xenograft models in mice.
References and notes (17)
- et al.
Nat. Chem. Biol.
(2008) Expert Opin. Ther. Patents
(2006)Expert Opin. Ther. Patents
(2007)et al.Rev. Recent Clin. Trials
(2007)et al.Cancer Res.
(2007)et al.Eur. J. Med. Chem.
(2008)et al.J. Biol. Chem.
(2008)et al.Bioorg. Med. Chem. Lett.
(2008)et al.Bioorg. Med. Chem. Lett.
(2008)et al.J. Med. Chem.
(2008)et al.Nat. Rev. Drug Disc.
(2008)et al.J. Med. Chem.
(2008)et al.J. Med. Chem.
(2008)et al.J. Med. Chem.
(2008)- et al.
Cancer Res.
(2003)et al.Clin. Cancer Res.
(2005)et al.Proc. Natl. Acad. Sci. U.S.A.
(2006) Chem. Abstr.
(1975)Aust. J. Chem.
(1977)et al.J. Chem. Res. Synop.
(2000)- et al.
Nature
(2001) - et al.
Cancer Metast. Rev.
(2003)et al.Nat. Rev. Mol. Cell Biol.
(2003)et al.Cancer Lett.
(2005)et al.Trends Mol. Med.
(2005)et al.Nat. Rev. Cancer
(2006)et al.Clin. Cancer Res.
(2006)et al.Cur. Opin. Gen. Dev.
(2008)et al.Clin. Cancer Res.
(2008) - et al.
Nat. Med.
(2003)et al.Front. Biosci.
(2005) - et al.
Curr. Med. Chem.
(2004)et al.Expert. Opin. Ther. Patents
(2005)et al.Oncologie
(2006)et al.The Oncologist
(2007)et al.Expert Opin. Investig. Drugs
(2007)et al.Expert Opin. Investig. Drugs
(2007)et al.Curr. Top. Med. Chem.
(2007)et al.Cur. Med. Chem.
(2007)
There are more references available in the full text version of this article.
Cited by (0)
- †
Present address: Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, CA 92008, USA.
Copyright © 2009 Elsevier Ltd. All rights reserved.